GREY:BITKF - Post by User
Comment by
facanadian1on May 04, 2004 10:54pm
242 Views
Post# 7442150
RE: interesting article
RE: interesting articleAs a Canadian-developed drug, Biolyse’s product is a rarity, says Bob Reichert, PhD, a member of the Expert Committee on Plant Products and employed with the Industrial Research Assistance Program of the National Research Council of Canada. For example, he says, during the last 10 years, only six new molecular entities have been discovered in Canada and commercialized: Vioxx® and Singulair® (Merck Frosst Canada & Co.), Visudyne® (QLT Inc.), Epivir® or 3TC (Shire BioChem Inc.), Levulan® PDT (DUSA Pharmaceuticals Inc.), and Diab II™ (Biotech Holdings Ltd.).